Inaugural Connor Cures Gala & Silent Auction
We are pleased to officially announce the First Connor Cures Gala & Silent Auction to be held at the Mayflower Hotel in Washington, DC on Saturday, September 21st, 2013 in honor of pediatric cancer awareness month.  The event will have an open bar, hors d’oeuvres, dinner, dessert, guest appearance by Redskins’ Legend Charles Mann and live music by the Reagan Years.  Dress will be cocktail attire, however ties are definitely optional.  Discount hotel rooms and parking are available for $169/night through the Renaissance Mayflower Hotel.   (Reservations have been kept open for a limited time, so book your room ASAP!)  The event starts at 630pm and ends at midnight.  It should be a wonderful night to have some fun while raising money for pediatric cancer research.

We still need YOUR help.  While we realize that economic times are difficult and many companies are reevaluating their charitable giving, this drug trial is critical and needs our support quickly. As those of you whose lives have been touched by cancer know, these children do not have the luxury of time. Many of these children have no hope for survival without these clinical trials. Your contribution has the power to make a difference in the lives of these children. Typical early-phase clinical trials require approximately $10,000 per child to successfully design and conduct. Therefore, your generous support is greatly needed and will be immensely appreciated.

Many of tables have been sold already, we still have a few Sponsorships, Tables and even Individual Tickets available.  We also have a number of amazing auction items to bid on, including trips to Ireland, Mexico and New York City.  

To Help with the Gala & Silent Auction:

  • Ticket Sales and Sponsorship Opportunities for this year’s Gala & Silent Auction can be found HERE
  • Auction Item Donations are greatly appreciated, but need to be in the system no later than midnight on Tuesday, September 10th.  Donations can be submitted online HERE.  
  • Volunteers may still be needed.  Please contact us via email at
As we’ve promised, here is where our money will go:  We are planning on investing into a new phase 1 trial for a pediatric cancer drug that focuses on malignant rhabdoid tumors (MRT) including ATRT and other SNF5-deficient pediatric tumors, the biologic driver of the malignant features.  It is a promising new agent that appears to target one of the main drivers of the development of ATRT and several other tumors.  It will be studied in a pediatrics study conducted by the Pediatric Oncology Experimental Therapeutics Investigators’ Consortium (POETIC).  

Thank you for providing hope to a child suffering from cancer and helping Connor Cure Cancer. For further information, please feel free to contact us directly at  

We hope to see you on September 21, 2013.